drugset / Trial / NCT05159128
A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants
RandomizedSequentialDouble-blindOther
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of JNJ-75105186 after single ascending oral dose administration in healthy Japanese participants and after single oral dose administration in healthy Chinese participants.
Timeline
- Start
- 2021-11-15
- Primary completion
- 2022-04-02
- Completion
- 2022-04-02
Outcome
Outcome not reported
Stopped (Business): “Business Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-75105186 | Unknown | — | Oral |
Indications
No indication recorded.